{
  "trial_id": "NCT01026220",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, weight, height, stage of Hodgkin lymphoma, presence of B symptoms, creatinine clearance, serum creatinine levels, total bilirubin levels, AST levels, ALT levels, shortening fraction by ECHO, ejection fraction by MUGA, FEV_1/FVC by pulmonary function tests, dyspnea at rest, exercise intolerance, pulse oximetry on room air, pregnancy status, QTc interval on 12-lead ECG, prior corticosteroid use, prior chemotherapy or radiotherapy, use of effective contraception, concurrent corticosteroid therapy, concurrent pegfilgrastim use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Male",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "stage of Hodgkin lymphoma",
        "presence of B symptoms",
        "creatinine clearance",
        "serum creatinine levels",
        "total bilirubin levels",
        "AST levels",
        "ALT levels",
        "shortening fraction by ECHO",
        "ejection fraction by MUGA",
        "FEV_1/FVC by pulmonary function tests",
        "dyspnea at rest",
        "exercise intolerance",
        "pulse oximetry on room air",
        "pregnancy status",
        "QTc interval on 12-lead ECG",
        "prior corticosteroid use",
        "prior chemotherapy or radiotherapy",
        "use of effective contraception",
        "concurrent corticosteroid therapy",
        "concurrent pegfilgrastim use"
      ]
    },
    "processed-gen-response": "Age, gender, weight, height, stage of Hodgkin lymphoma, presence of B symptoms, creatinine clearance, serum creatinine levels, total bilirubin levels, AST levels, ALT levels, shortening fraction by ECHO, ejection fraction by MUGA, FEV_1/FVC by pulmonary function tests, dyspnea at rest, exercise intolerance, pulse oximetry on room air, pregnancy status, QTc interval on 12-lead ECG, prior corticosteroid use, prior chemotherapy or radiotherapy, use of effective contraception, concurrent corticosteroid therapy, concurrent pegfilgrastim use."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Stage of Disease, B Symptoms Presence, Creatinine Clearance, Total Bilirubin, AST/ALT Levels, Ejection Fraction, FEV_1/FVC, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Stage of Disease",
        "B Symptoms Presence",
        "Creatinine Clearance",
        "Total Bilirubin",
        "AST/ALT Levels",
        "Ejection Fraction",
        "FEV_1/FVC"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Stage of Disease, B Symptoms Presence, Creatinine Clearance, Total Bilirubin, AST/ALT Levels, Ejection Fraction, FEV_1/FVC"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Hodgkin Lymphoma Stage, B Symptoms, Creatinine Clearance, Serum Creatinine, Total Bilirubin, AST, ALT, Shortening Fraction, Ejection Fraction, FEV1/FVC, Pulse Oximetry.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Hodgkin Lymphoma Stage",
        "B Symptoms",
        "Creatinine Clearance",
        "Serum Creatinine",
        "Total Bilirubin",
        "AST",
        "ALT",
        "Shortening Fraction",
        "Ejection Fraction",
        "FEV1/FVC",
        "Pulse Oximetry"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Hodgkin Lymphoma Stage, B Symptoms, Creatinine Clearance, Serum Creatinine, Total Bilirubin, AST, ALT, Shortening Fraction, Ejection Fraction, FEV1/FVC, Pulse Oximetry."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, weight, height, race, ethnicity, performance status, disease stage, presence of B symptoms, creatinine clearance, serum creatinine, total bilirubin, AST, ALT, shortening fraction, ejection fraction, FEV1/FVC, pulse oximetry, QTc interval, prior corticosteroid use, presence of large mediastinal mass.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "performance status",
        "disease stage",
        "presence of B symptoms",
        "creatinine clearance",
        "serum creatinine",
        "total bilirubin",
        "AST",
        "ALT",
        "shortening fraction",
        "ejection fraction",
        "FEV1/FVC",
        "pulse oximetry",
        "QTc interval",
        "prior corticosteroid use",
        "presence of large mediastinal mass"
      ]
    },
    "processed-gen-response": "Age, sex, weight, height, race, ethnicity, performance status, disease stage, presence of B symptoms, creatinine clearance, serum creatinine, total bilirubin, AST, ALT, shortening fraction, ejection fraction, FEV1/FVC, pulse oximetry, QTc interval, prior corticosteroid use, presence of large mediastinal mass."
  }
}